• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Yen-ta Chen, Cheuk-Kwan Sun, +11 authors Hon-Kan Yip
  • Medicine
  • Journal of Translational Medicine
  • 2011 (First Publication: 5 May 2011)
  • BackgroundReactive oxygen species are important mediators exerting toxic effects on various organs during ischemia-reperfusion (IR) injury. We hypothesized that adipose-derived mesenchymal stem cellsContinue Reading
  • Jiunn-Jye Sheu, Tzu-hsien Tsai, +10 authors Hon-Kan Yip
  • Medicine
  • Critical care medicine
  • 2010 (First Publication: 1 September 2010)
  • OBJECTIVES This study tested the hypothesis that early extracorporeal membrane oxygenator offered additional benefits in improving 30-day outcomes in patients with acute ST-segment elevationContinue Reading
  • Kun-Chen Lin, Hon-Kan Yip, +11 authors Mel S Lee
  • Medicine
  • International journal of cardiology
  • 2016 (First Publication: 1 August 2016)
  • BACKGROUND In this study, we tested the hypothesis that a combined adipose-derived mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy protected rat kidney from acute ischemia-reperfusionContinue Reading
  • Cheuk-Kwan Sun, Chia-Lo Chang, +7 authors Hon-Kan Yip
  • Medicine
  • Critical care medicine
  • 2012 (First Publication: 1 April 2012)
  • OBJECTIVES Mesenchymal stem cells have previously been shown to offer significant therapeutic benefit in ischemic organ injuries. This study aimed at investigating the therapeutic role of adiposeContinue Reading
  • Cheuk-Kwan Sun, Fan-Yen Lee, +8 authors Hon-Kan Yip
  • Medicine
  • The Journal of pharmacology and experimental…
  • 2009 (First Publication: 1 September 2009)
  • We investigated whether early combined cilostazol and bone marrow-derived endothelial progenitor cell (BMDEPC) treatment offers synergistic benefit in ameliorating monocrotaline (MCT)-inducedContinue Reading